HealthEquity, Inc. $HQY Stock: Motley Fool Asset Management LLC Decreases Stake

Motley Fool Asset Management LLC lessened its position in HealthEquity, Inc. (NASDAQ:HQY) by 16.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 77,542 shares of the company’s stock after selling 15,501 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HealthEquity were worth $6,859,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Leonteq Securities AG lifted its stake in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Silvant Capital Management LLC bought a new position in shares of HealthEquity during the 2nd quarter worth approximately $35,000. Axiom Investment Management LLC bought a new position in shares of HealthEquity during the 1st quarter worth approximately $33,000. Public Employees Retirement System of Ohio bought a new position in shares of HealthEquity during the 2nd quarter worth approximately $39,000. Finally, International Assets Investment Management LLC raised its holdings in shares of HealthEquity by 18,333.3% in the first quarter. International Assets Investment Management LLC now owns 553 shares of the company’s stock valued at $46,000 after purchasing an additional 550 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $101.34 on Thursday. The company has a market cap of $8.38 billion, a price-to-earnings ratio of 36.58, a PEG ratio of 1.64 and a beta of 0.24. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The company’s fifty day simple moving average is $95.46 and its 200 day simple moving average is $88.91. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. The firm had revenue of $350.73 million for the quarter, compared to analyst estimates of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. HealthEquity’s revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, research analysts forecast that HealthEquity, Inc. will post 3.93 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on HQY shares. Raymond James Financial reissued a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. BTIG Research reiterated a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th. Finally, BMO Capital Markets lifted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $113.53.

Insider Buying and Selling at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.